A Study to Evaluate the Effect of Food on the Level of Circulating Elafibranor in Healthy Participants After Intake of a Single Tablet

Inclusion Criteria : * Willingness to remain at the clinic for the required duration and willingness to return to the clinic for the follow-up evaluation as specified in the protocol * Healthy participants as determined by medical evaluation at the screening visit including medical history, physical examination, laboratory tests, electrocardiogram (ECG) and vital signs monitoring * Laboratory parameters within the normal range of the laboratory (haematological, blood biochemistry, urinalysis) at screening and baseline visit of each period. Individual values out of the normal range can be accepted if judged not clinically significant by the investigator * Normal electrocardiogram (ECG) recording on a 12-lead ECG at screening and baseline visit of each period: * 120≤PR≤220 ms, * QRS\<110 ms, * QTcF≤430 ms for male and * ≤450 ms for female, * No evidence of sinus node automaticity or abnormal conduction, or rhythm disorders of concern, except as considered not clinically significant by the investigator. Out-of-range values that are not clinically significant (as determined by the investigator) may be repeated twice during screening and baseline visits of each period and the participant may be enrolled if at least one repeated value is within the range noted above. * Normal blood pressure (BP) and heart rate (HR) at screening and baseline visits of each period after 5 minutes in supine position: * 90 mmHg≤systolic blood pressure (SBP)≤145 mmHg, * 50 mmHg≤diastolic …